UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Lipoprotein Particle Analysis by Nuclear Magnetic Resonance Spectroscopy

Clinics in laboratory medicine, 2006-12, Vol.26 (4), p.847-870

2006

Volltextzugriff (PDF)

The extended lipid panel assay: a clinically-deployed high-throughput nuclear magnetic resonance method for the simultaneous measurement of lipids and Apolipoprotein B

Lipids in health and disease, 2020-12, Vol.19 (1), p.1-247, Article 247

2020

Volltextzugriff (PDF)

Sex and Age Differences in Lipoprotein Subclasses Measured by Nuclear Magnetic Resonance Spectroscopy: The Framingham Study

Clinical chemistry (Baltimore, Md.), 2004-07, Vol.50 (7), p.1189-1200

2004

Volltextzugriff (PDF)

High Betaine, a Trimethylamine N-Oxide Related Metabolite, Is Prospectively Associated with Low Future Risk of Type 2 Diabetes Mellitus in the PREVEND Study

Journal of clinical medicine, 2019-11, Vol.8 (11), p.1813

2019

Volltextzugriff (PDF)

Characterization of LP-Z Lipoprotein Particles and Quantification in Subjects with Liver Disease Using a Newly Developed NMR-Based Assay

Journal of clinical medicine, 2020-09, Vol.9 (9), p.2915

2020

Volltextzugriff (PDF)

TMAO is Associated with Mortality: Impact of Modestly Impaired Renal Function

Scientific reports, 2017-10, Vol.7 (1), p.13781-9, Article 13781

2017

Volltextzugriff (PDF)

Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease

Arteriosclerosis, thrombosis, and vascular biology, 1998-07, Vol.18 (7), p.1046-1053

1998

Volltextzugriff (PDF)

Lower Plasma Magnesium, Measured by Nuclear Magnetic Resonance Spectroscopy, is Associated with Increased Risk of Developing Type 2 Diabetes Mellitus in Women: Results from a Dutch Prospective Cohort Study

Journal of clinical medicine, 2019-02, Vol.8 (2), p.169

2019

Volltextzugriff (PDF)

NMR measurement of LDL particle number using the Vantera® Clinical Analyzer

Clinical biochemistry, 2014-11, Vol.47 (16-17), p.203-210

2014

Volltextzugriff (PDF)

Circulating trimethylamine N-oxide levels following fish or seafood consumption

European journal of nutrition, 2022-08, Vol.61 (5), p.2357-2364

2022

Volltextzugriff (PDF)

NMR quantification of trimethylamine-N-oxide in human serum and plasma in the clinical laboratory setting

Clinical biochemistry, 2017-11, Vol.50 (16-17), p.947-955

2017

Volltextzugriff (PDF)

Blood Mg2+ is more closely associated with hyperglycaemia than with hypertriacylglycerolaemia: the PREVEND study

Diabetologia, 2019-09, Vol.62 (9), p.1732-1734

2019

Volltextzugriff (PDF)

HDL particle number measured on the Vantera®, the first clinical NMR analyzer

Clinical biochemistry, 2015-02, Vol.48 (3), p.148-155

2015

Volltextzugriff (PDF)

Measurement issues related to lipoprotein heterogeneity

The American journal of cardiology, 2002-10, Vol.90 (8), p.22-29

2002

Volltextzugriff (PDF)

Genome- and CD4+ T-cell methylome-wide association study of circulating trimethylamine-N-oxide in the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN)

Journal of nutrition & intermediary metabolism, 2017-06, Vol.8 (C), p.1-7

2017

Volltextzugriff (PDF)

Blood Mg 2+ is more closely associated with hyperglycaemia than with hypertriacylglycerolaemia: the PREVEND study

Diabetologia, 2019-09, Vol.62 (9), p.1732

2019

Volltextzugriff (PDF)

Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement

Clinical chemistry (Baltimore, Md.), 1992-09, Vol.38 (9), p.1632-1638

1992

Volltextzugriff (PDF)

Improvements to the method of lipoprotein analysis by NMR

Atherosclerosis, 1994-08, Vol.108, p.S192-S192

1994

Volltextzugriff (PDF)

Persistent changes in lipoprotein lipids after a single infusion of ascending doses of MDCO-216 (apoA-IMilano/POPC) in healthy volunteers and stable coronary artery disease patients

Atherosclerosis, 2016-12, Vol.255, p.17-24

2016

Volltextzugriff (PDF)

High-Density Lipoprotein Subfractions and Cholesterol Efflux Capacities After Infusion of MDCO-216 (Apolipoprotein A-IMilano/Palmitoyl-Oleoyl-Phosphatidylcholine) in Healthy Volunteers and Stable Coronary Artery Disease Patients

Arteriosclerosis, thrombosis, and vascular biology, 2016-04, Vol.36 (4), p.736-742

2016

Volltextzugriff (PDF)

Incubation of MDCO-216 (ApoA-IMilano/POPC) with Human Serum Potentiates ABCA1-Mediated Cholesterol Efflux Capacity, Generates New Prebeta-1 HDL, and Causes an Increase in HDL Size

Journal of Lipids, 2014-01, Vol.2014 (2014), p.n1-8

2014

Volltextzugriff (PDF)

Abstract 238: Incubation of MDCO216 With Human Serum or Plasma Potentiates ABCA1-Mediated Cholesterol Efflux Capacity, Increases Prebeta-1 HDL and Causes a Shift From Small to Large Alpha HDL Particles

Arteriosclerosis, thrombosis, and vascular biology, 2014-05, Vol.34 (suppl_1)

2014

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(22)

Sprache

Englisch
(22)

Erscheinungsjahr

n.n

Thema

Science & Technology
(18)
Life Sciences & Biomedicine
(17)
Humans
(13)
Cardiovascular Disease
(6)
Male
(6)
Medical Laboratory Technology
(6)
Middle Aged
(6)
Nuclear Magnetic Resonance Spectroscopy
(6)
Adult
(5)
Female
(5)
Lipids
(5)
Lipoproteins - Blood
(5)
Magnetic Resonance Spectroscopy - Methods
(5)
Aged
(4)
Cardiovascular System & Cardiology
(4)
Lipoproteins
(4)
Lipoproteins, Hdl - Blood
(4)
Lipoproteins, Vldl - Blood
(4)
Apolipoproteins
(3)
Atherosclerosis
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Lipoprotein Particle Analysis by Nuclear Magnetic Resonance Spectroscopy

The extended lipid panel assay: a clinically-deployed high-throughput nuclear magnetic resonance method for the simultaneous measurement of lipids and Apolipoprotein B

Sex and Age Differences in Lipoprotein Subclasses Measured by Nuclear Magnetic Resonance Spectroscopy: The Framingham Study

High Betaine, a Trimethylamine N-Oxide Related Metabolite, Is Prospectively Associated with Low Future Risk of Type 2 Diabetes Mellitus in the PREVEND Study

Characterization of LP-Z Lipoprotein Particles and Quantification in Subjects with Liver Disease Using a Newly Developed NMR-Based Assay

TMAO is Associated with Mortality: Impact of Modestly Impaired Renal Function

Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease

Lower Plasma Magnesium, Measured by Nuclear Magnetic Resonance Spectroscopy, is Associated with Increased Risk of Developing Type 2 Diabetes Mellitus in Women: Results from a Dutch Prospective Cohort Study

NMR measurement of LDL particle number using the Vantera® Clinical Analyzer

Circulating trimethylamine N-oxide levels following fish or seafood consumption

NMR quantification of trimethylamine-N-oxide in human serum and plasma in the clinical laboratory setting

Blood Mg2+ is more closely associated with hyperglycaemia than with hypertriacylglycerolaemia: the PREVEND study

HDL particle number measured on the Vantera®, the first clinical NMR analyzer

Measurement issues related to lipoprotein heterogeneity

Genome- and CD4+ T-cell methylome-wide association study of circulating trimethylamine-N-oxide in the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN)

Blood Mg 2+ is more closely associated with hyperglycaemia than with hypertriacylglycerolaemia: the PREVEND study

Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement

Improvements to the method of lipoprotein analysis by NMR

Persistent changes in lipoprotein lipids after a single infusion of ascending doses of MDCO-216 (apoA-IMilano/POPC) in healthy volunteers and stable coronary artery disease patients

High-Density Lipoprotein Subfractions and Cholesterol Efflux Capacities After Infusion of MDCO-216 (Apolipoprotein A-IMilano/Palmitoyl-Oleoyl-Phosphatidylcholine) in Healthy Volunteers and Stable Coronary Artery Disease Patients

Incubation of MDCO-216 (ApoA-IMilano/POPC) with Human Serum Potentiates ABCA1-Mediated Cholesterol Efflux Capacity, Generates New Prebeta-1 HDL, and Causes an Increase in HDL Size

Abstract 238: Incubation of MDCO216 With Human Serum or Plasma Potentiates ABCA1-Mediated Cholesterol Efflux Capacity, Increases Prebeta-1 HDL and Causes a Shift From Small to Large Alpha HDL Particles

Suchergebnisse filtern